Short-term Celecoxib intervention is a safe and effective chemopreventive for gastric carcinogenesis based on a Mongolian gerbil model

doi:10.3748/wjg.15.4907

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 39

This Article

Reference Citation Analysis (0)

(0)

(4835)

(10)

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Original Article

World J Gastroenterol. Oct 21, 2009; 15(39): 4907-4914
Published online Oct 21, 2009. doi: 10.3748/wjg.15.4907

Full Size Figure Download Figure

Figure 2 Typical adenocarcinoma in the pyloric mucosa of H pylori-infected MGs. Shown is a typical well-differentiated adenocarcinoma (A, B) stained with HE. Images were obtained at × 100 (A) and × 400 (B).

Citation: Kuo CH, Hu HM, Tsai PY, Wu IC, Yang SF, Chang LL, Wang JY, Jan CM, Wang WM, Wu DC. Short-term Celecoxib intervention is a safe and effective chemopreventive for gastric carcinogenesis based on a Mongolian gerbil model. World J Gastroenterol 2009; 15(39): 4907-4914
URL: https://www.wjgnet.com/1007-9327/full/v15/i39/4907.htm
DOI: https://dx.doi.org/10.3748/wjg.15.4907

Kuo CH, Hu HM, Tsai PY, Wu IC, Yang SF, Chang LL, Wang JY, Jan CM, Wang WM, Wu DC. Short-term Celecoxib intervention is a safe and effective chemopreventive for gastric carcinogenesis based on a Mongolian gerbil model. World J Gastroenterol 2009; 15(39): 4907-4914 [PMID: 19842220 DOI: 10.3748/wjg.15.4907]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.